Blood Sugar News and Research

RSS

Blood sugar concentration, or glucose level, refers to the amount of glucose present in the blood of a human or animal. Normally, in mammals the blood glucose level is maintained at a reference range between about 3.6 and 5.8 mM (mmol/l). It is tightly regulated as a part of metabolic homeostasis.

Study identifies 9 novel genes linked to gestational diabetes

The largest genetic study of gestational diabetes to date has led to a discovery of nine novel genetic regions linked to this severe and common pregnancy complication.

5 Jan 2024

Bipolar disorder cuts lives short more than smoking

Having bipolar disorder – a serious mental illness that can cause both manic and depressed moods – can make life more challenging.

4 Jan 2024

GLP-1R agonist liraglutide rapidly improves insulin sensitivity in pre-diabetics, independent of weight loss

A new study published in the journal Diabetes demonstrates that a glucagon-like peptide-1 receptor (GLP-1R) agonist, a member of a class of medication used to treat Type 2 diabetes and obesity, can lead to a rapid improvement in insulin sensitivity.

4 Jan 2024

Pre-pregnancy stress raises blood sugar during pregnancy, study finds

A new Journal of the Endocrine Society study among women attending a fertility center found that those with more stress before pregnancy had higher blood sugar levels during pregnancy, which is a sign of weaker cardiovascular health.

4 Jan 2024

Maternal stress during preconception associated with higher blood glucose levels, study finds

Stress during pregnancy is known to influence health outcomes, but a new study from Mass General Brigham researchers suggests that stress levels before pregnancy are also important to evaluate.

4 Jan 2024

Pregnancy weight and blood markers may predict poor outcomes for gestational diabetes

Pregnancy weight and biochemical markers measured in blood from women with gestational diabetes mellitus (GDM) were related to increased risk of poor pregnancy outcomes, suggesting a new direction for precision diagnostics, according to researchers.

3 Jan 2024

Combination therapy of dapagliflozin and semaglutide shows superior efficacy in type 2 diabetes management

Study demonstrates that combining dapagliflozin and semaglutide significantly improves glycemic control and other health parameters in type 2 diabetes patients, outperforming dapagliflozin alone.

3 Jan 2024

New research project seeks to find innovative treatment pathways for Type 2 diabetes and obesity

A team of Virginia Tech researchers was awarded nearly $2 million from the National Institute of Diabetes and Digestive and Kidney Disease, part of the National Institutes of Health, to explore novel approaches for treating Type 2 diabetes and obesity.

3 Jan 2024

Moderate low-carb diet safe and effective for adults with type 1 diabetes

A moderate low-carbohydrate diet for adults with type 1 diabetes has advantages over traditional diet.

20 Dec 2023

Shattering myths: Study reveals new insights on type 1 diabetes and obesity link

Review examines the relationship between type 1 diabetes and weight disorders, debunking myths about T1D and offering recommendations for future research and therapeutic interventions.

18 Dec 2023

From diabetes drug to anti-inflammation powerhouse: The unexpected evolution of GLP-1

Research pioneer Dr. Daniel Drucker has much to be proud of, as the GLP-1-based diabetes drugs hailing from his early research are named 2023 breakthrough of the year by the Science Magazine.

18 Dec 2023

Study reveals higher post-meal insulin responses linked to lower diabetes risk over five years

Study investigated the long-term cardiometabolic effects of postprandial insulin hypersecretion in pregnant women, finding that higher insulin responses post-meals were linked to better beta-cell function and lower glucose levels, with reduced risk of pre-diabetes or diabetes over a 5-year period.

17 Dec 2023

Experimental drug paired with a standard-care medication offers hope for kidney disease patients

In a clinical trial of patients with chronic kidney disease, an experimental drug significantly reduced albuminuria -; albumin in urine, a sign of kidney damage -; for 50% of participants.

15 Dec 2023

U.S. adults get a third of daily added sugar from snacking, research shows

Snacks constitute almost a quarter of a day's calories in U.S. adults and account for about one-third of daily added sugar, a new study suggests.

15 Dec 2023

How safe are GLP-1R agonists in early pregnancy?

JAMA Internal Medicine study examines the safety of GLP-1 receptor agonists and other second-line antidiabetic medications during early pregnancy, finding no significant increase in congenital anomalies compared to insulin use.

14 Dec 2023

High insulin response can be your health ally, study says

Researchers at Sinai Health have unearthed vital information about the relationship between insulin levels after eating and long-term heart and metabolic health.

13 Dec 2023

St. Jude study sheds light on prediabetes prevalence and diabetes risk in childhood cancer survivors

A study from St. Jude Children's Research Hospital sheds light on the incidence of prediabetes and diabetes in childhood cancer survivors for better prevention and treatment.

13 Dec 2023

Epigenetic changes can contribute to the development of type 2 diabetes

Do epigenetic changes cause type 2 diabetes, or do the changes occur only after a person has become ill? A new study by researchers at Lund University provides increased support for the idea that epigenetic changes can cause type 2 diabetes.

13 Dec 2023

Adherence to second-line drugs for Type 2 diabetes can be hit or miss, study reports

Most patients with Type 2 diabetes will end up needing to add a second-line medication after metformin -; the go-to primary drug for glucose management -; to control their blood sugar levels.

12 Dec 2023

Tirzepatide maintains weight loss and improves cardiometabolic health in SURMOUNT-4 trial

The current class of anti-obesity drugs is proving remarkably effective at removing excess pounds. However, a phase 3 randomized clinical trial led by researchers at Weill Cornell Medicine and NewYork-Presbyterian found that people who stopped taking the medication regained much of that weight within a year.

11 Dec 2023

Blood Sugar News and Research

Further Reading

Study identifies 9 novel genes linked to gestational diabetes

Bipolar disorder cuts lives short more than smoking

GLP-1R agonist liraglutide rapidly improves insulin sensitivity in pre-diabetics, independent of weight loss

Pre-pregnancy stress raises blood sugar during pregnancy, study finds

Maternal stress during preconception associated with higher blood glucose levels, study finds

Pregnancy weight and blood markers may predict poor outcomes for gestational diabetes

Combination therapy of dapagliflozin and semaglutide shows superior efficacy in type 2 diabetes management

New research project seeks to find innovative treatment pathways for Type 2 diabetes and obesity

Moderate low-carb diet safe and effective for adults with type 1 diabetes

Shattering myths: Study reveals new insights on type 1 diabetes and obesity link

From diabetes drug to anti-inflammation powerhouse: The unexpected evolution of GLP-1

Study reveals higher post-meal insulin responses linked to lower diabetes risk over five years

Experimental drug paired with a standard-care medication offers hope for kidney disease patients

U.S. adults get a third of daily added sugar from snacking, research shows

How safe are GLP-1R agonists in early pregnancy?

High insulin response can be your health ally, study says

St. Jude study sheds light on prediabetes prevalence and diabetes risk in childhood cancer survivors

Epigenetic changes can contribute to the development of type 2 diabetes

Adherence to second-line drugs for Type 2 diabetes can be hit or miss, study reports

Tirzepatide maintains weight loss and improves cardiometabolic health in SURMOUNT-4 trial

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News